About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

LDCT-SC-FI Low-dose CT Screening for Lung Cancer | Clinical Trials | Clareo Health

Back to clinical trial search

Active Not RecruitingNANCT05630950

LDCT-SC-FI Low-dose CT Screening for Lung Cancer

This is a randomized phase II trial investigating different smoking cessation methods in study subjects undergoing lung cancer screening with low-dose CT (LDCT). The study also evaluates feasibility a...

Lead sponsor: Oulu University Hospital•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Oulu University Hospital

Age

50 - 74 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Able to provide written informed consent
•Age between 50-74
•Smoked ≥ 15 cigarettes/day for ≥ 25 years or smoked ≥ 10 cigarettes/day for ≥ 30 years and are active smokers (smoking during the last two weeks)
•Access to a smartphone (iPhone or Android)

Exclusion Criteria

•A moderate or bad self-reported health; e.g. unable to climb two flights of stairs
•Body weight ≥ 140 kilogram
•Current or past melanoma, lung, renal or breast cancer
•A chest CT examination less than one year before inclusion
•Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
•Subject is unwilling or unable to comply with treatment and trial instructions
•Any condition that study investigators consider an impediment to safe trial participation

Related studies

LUNG-07: Advancing Precision-Based Lung Cancer Screening: Implementation, AI-Guided Risk Stratification, and Biomarker Integration (CREST AI)

NCT07408531 · Lung Cancer Screening

Advancing Lung Cancer Screening One Text at a Time

NCT07227480 · Lung Cancer Screening

Enrolling By InvitationNA

Facilitation of Information eXchange for Shared Decision Making for Lung Cancer Screening

NCT07517692 · Lung Cancer Screening

Enrolling By InvitationNA

Centralized Lung Cancer Screening Engagement in At-Risk Populations

NCT07216144 · Lung Cancer Screening

Active Not RecruitingNA

Multilevel Interventions to Increase Adherence to Lung Cancer Screening

NCT05747443 · Lung Cancer, Lung Cancer Screening

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 24, 2025Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

PhaseNA

Enrollment200

Start dateNov 2022

Last updatedAug 24, 2025

Condition

Lung Cancer Screening

Locations shown

Oulu University Hospital

Oulu

Vaasa Central Hospital

Vaasa

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 24, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions